immuron.com.au - Wutah bathi EPS kuartalan IMRN

IMRN (Immuron Inc) - tandha merek perusahaan

How does the profitability of Immuron Limited (IMRN) depend on tourist flows and raw material availability? The current quarterly EPS growth rate reflects the asset's dynamics, where the 47.90 mark indicates the current state. The sale of low-capital-intensity over-the-counter products ensures stability. Growth in the customer base is supported by US military government contracts and the dietary supplement status of Travelan, which facilitates market expansion.

Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan Immuron (IMRN): kanggo periode 04.07.2022 - 10.11.2026

IMRN (Immuron Limited): rincian analitis lan laporan miturut indikator

- rega saham lan konsensus proyeksi valuasi:
Kutipan saham immuron.com.au|IMRN - Rega prakiraan analis
- rincian nilai pasar emiten:
Kapitalisasi pasar Immuron Inc|IMRN - Rega Tumbas Perusahaan
- indikator nilai aset resik miturut neraca:
Aset Bersih saben Siji Saham Immuron|IMRN - Aset Bersih Perusahaan|Rasio Nilai Pasar marang Nilai Buku immuron.com.au|IMRN - Gunggung Aset Perusahaan
- data tingkat utang lan likuiditas finansial:
Rasio Total Utang marang Ekuitas Immuron Limited|IMRN - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas immuron.com.au|IMRN - Kewajiban utang agregat|Rasio utang marang kapitalisasi buku Immuron Inc|IMRN - Utang jangka dawa|Utang jangka cendhak perusahaan Immuron|Indikator likuiditas cepet immuron.com.au
- rincian bathi lan kelipatan pasar:
IMRN - Bathi pungkasan|Bathi sing dikarepake Immuron Limited|IMRN - Rasio rega marang bathi|Pangali Forward P/E immuron.com.au|IMRN - Kapitalisasi marang bathi resik kanthi nimbang wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Immuron Inc|IMRN - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) Immuron|IMRN - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan immuron.com.au|IMRN - Wutah bathi resik saben siji saham kanggo taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Immuron Limited
Ringkesan analitik perusahaan:Immuron Limited
Produk dadi immuron.com.au

This metric measures the quarterly dynamics of earnings per share, reflecting the actual efficiency of business capitalization and the risk of overpaying for inflated expectations. By analyzing the quarterly EPS growth vector on GURU.Markets, an investor can see how the commercial success of Travelan and the immunoglobulin ecosystem of Immuron Limited (IMRN) convert into financial results, confirming the stability of the company's market positions.

Analisis perusahaan pesaing

PHAT (Phathom Pharmaceuticals, Inc.) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|TERN: Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|IRWD (Ironwood Pharma) - Wutah bathi EPS kuartalan|Curanex (CURX) - Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Evoke Pharma, Inc. (EVOK)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan enterothera.com ENTO|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan RedHill Biopharma Ltd. RDHL|PALI - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|JAGX: Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|BIOR - Wutah bathi EPS kuartalan|Morphic Holding, Inc. (MORF) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan